Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
Files
Publication date
2019
Authors
Blokland, S L M
Hillen, Maarten R.
Wichers, Catharina G. K.
Zimmermann, Maili
Kruize, AA
Radstake, Timothy R D J
Broen, Jasper C A
Van Roon, J. A G
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
B cells, Sjögren's syndrome, T cells, mTOR, rapamycin, Immunology and Allergy, Rheumatology, Immunology
Citation
Blokland, S L M, Hillen, M R, Wichers, C G K, Zimmermann, M, Kruize, A A, Radstake, T R D J, Broen, J C A & van Roon, J A G 2019, 'Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome : mTOR inhibition as a novel therapeutic strategy to halt immunopathology?', RMD Open, vol. 5, no. 1, e000701. https://doi.org/10.1136/rmdopen-2018-000701